Clinical Operations Program Associate Director

100,000+ That’s how many patients participate in our clinical trials at any given time. GCO is Novartis’ powerhouse of Global Clinical Operations, redesigned to enable faster trial recruitment and enhanced trial delivery resulting in more timely access for patients to potential novel treatments. Every day, we are the link between science and medicine - imagine the impact you could have as a Clinical Operations Program Associate Director
GCO
The Clinical Operations Program Associate Director (COPaD) is accountable for the oversight, coordination and development of early viability assessments, global feasibility assessments (pre-IMB and trial feasibility), recruitment projections and allocation strategies for the assigned trials and programs. As a key member of the GCO sub-team, the COPaD will provide precise oversight and ensure alignment with the overarching strategy and GCO operational position adding directly into the feasibility strategies.
The COPaD scope of activities include pre-IMB project feasibility and/or early viability assessment, trial feasibility assessment, validation and refinement of trial allocation strategy, including scenario planning and risk management, and any re-feasibility assessments, as applicable. Drives operational excellence through overall project milestone management and system requirements, process improvement and knowledge sharing across clinical indication(s)/program(s) within Development Unit. Navigates in a matrix environment and adjusts quickly to business needs.
Leads analyses of external and internal data to validate and refine strategic allocation of assigned trials and programs enabling accurate overall decision making by Clinical Operations Program Head (COPH) and GCO sub-team.

Key partner to the Feasibility Managers and CRMAs to ensure overall quality and delivery of feasibility assessments from initial site identification until final site allocation

**Your key responsibilities**:

- Accountable for leading and conducting the end-to-end feasibility process starting from early viability assessments as well as pre-IMB and trial feasibilities and for developing strategic allocation, site selection and recruitment plans scenarios for the assigned programs and trials.
- As part of the GCO sub-team, remains as the point of contact for assigned program and trial feasibilities, leading the multidisciplinary feasibility teams to develop, validate and refine allocation strategy, including timelines, scenarios, and risk mitigation plans. Identifies and resolves events in the indication landscape that represent operational risks for the execution of clinical trials within the given indication/program. Leads integration of regional and local indication strategies within global execution plans.
- Partners closely with the country feasibility team to align on the end-to-end quality of feasibility product
- Key contributor to the Operational Execution Plan:
a)Collection and analysis of internal and external data (i.e. local treatment standard of care, available treatment options approved/reimbursed, local prevalence and access to targeted populations) through analysis of clinical intelligence data describing the indication landscape including scientific and epidemiology data, competitive intelligence, treatment paradigms and potential site partners globally, from external and internal research data sources including analysis of historical data related to site performance (data quality, start-up cycle time, patient enrolment), based on the clinical intelligence package received from the Health Insights Manager and other data sources
b)Defines an optimal geographic country footprint and proposed sites for participation in a clinical trial and supports COPH & GCO sub-team on final site allocation.
c)Designs and executes the feasibility process by developing feasibility assessment/survey, coordinates execution of feasibility at country level, evaluates prospective sites on their operational and medical capability to conduct the study, and provides a thorough analysis and summary of feasibility outcome to the GCO sub-team
d)Develops and proposes risk management strategies for clinical trial(s) highlighting feasibility-related operational risks and mitigation actions for program and trial feasibility and allocation.
e)In collaboration with the COPH, GCO sub-team and feasibility team, defines the final allocation and selected countries and sites
f)Performs ongoing analysis and reassessment of feasibility against recruitment throughout the lifecycle of the trial, including re-allocation or corrective actions when needed and alignment with regional teams.
- Responsible for the creation and maintenance of patient enrolment forecast, at study levels

a) Based on prior experience and analytics, works with COPH to define the patient enrolment scenario that can be flexible based on the study objectives or meet specific study requirements (i.e., enrolment objectives, endpoints, cost, tim